DEF 14AThe Ballot
ArriVent BioPharma, Inc. files DEF 14A
Filed Apr 28, 2026 · 2mo ago · Accession 0001104659-26-050337
Plain English
Proxy statement — executive pay, board nominees, and shareholder votes.
Read the source below for the full document.
Filing details
- Company
- ArriVent BioPharma, Inc.
- Ticker
- AVBP
- CIK
- 1868279
- Form type
- DEF 14A
- Filing date
- Apr 28, 2026
- Report date
- Jun 18, 2026
- Document
- tm261626-1_def14a.htm
- Size
- 1.8 MB